AVICEDA THERAPEUTICS
Aviceda Therapeutics is a late-stage, pre-clinical biotech company developing drugs for treating glyco-immune diseases. The company focuses on the next generation of immunomodulators by harnessing the power of glycobiology to address the innate immune system and chronic non-resolving inflammation specifically and profoundly. A combination of cutting-edge technologies and deep biological insights form Aviceda’s engine of transformative product creation. Aviceda uses its cell-based high-through... put screening (HTS) platform to rapidly screen, select, and optimize ligands based on maximum affinity and specificity for each different type of innate immune cell. . The company's products are for eye diseases, fibrosis, neurology, and oncology, for eye diseases like AVD-104, AVD-302, AVD-401 for dry eye, diabetic retinopathy, and retinoblastoma respectively AVD-601, AVD-701 and AVD-801 for oncology, neurology, and fibrosis respectively.
AVICEDA THERAPEUTICS
Industry:
Biotechnology Health Care Life Science Pharmaceutical Therapeutics
Founded:
2018-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.avicedarx.com
Total Employee:
11+
Status:
Active
Contact:
617-332-0741
Total Funding:
69.31 M USD
Technology used in webpage:
Domain Not Resolving IPv6 U.S. Server Location Canadian Server Location BunnyCDN Netlify Forms
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
Dewpoint Therapeutics
Dewpoint Therapeutics is a biotech company developing a drug platform that targets biomolecular condensates.
Expressable
Expressable is an online speech therapy practice for those with a communication disorder.
HepaRegeniX
HepaRegeniX is developing drugs for treating acute and chronic liver diseases.
New Amsterdam Pharma
New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.
Palvella Therapeutics
Palvella Therapeutics focuses on relentlessly and selflessly serving abandoned patient populations with therapies.
Biosplice Therapeutics
Biosplice Therapeutics is in the medical research and development for tissue-level regeneration.
Wave Life Sciences
Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling diseases
Current Employees Featured
Mohamed Genead Co-Founder, CEO & President, Executive Board Director @ Aviceda Therapeutics
Co-Founder, CEO & President, Executive Board Director
2018-05-01
Michael Tolentino Co-Founder and CTO @ Aviceda Therapeutics
Co-Founder and CTO
Derek Kunimoto COO & Co-Founder @ Aviceda Therapeutics
COO & Co-Founder
Christopher Scott Scientific Co-Founder @ Aviceda Therapeutics
Scientific Co-Founder
Founder
Official Site Inspections
http://www.avicedarx.com Semrush global rank: 10.43 M Semrush visits lastest month: 232
- Host name: acd89244c803f7181.awsglobalaccelerator.com
- IP address: 75.2.60.5
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Aviceda Therapeutics"
Aviceda Therapeutics - Crunchbase Company Profile
Aviceda Therapeutics is a late-stage, pre-clinical biotech company developing drugs for treating glyco-immune diseases. The company focuses on the next …See details»
About Aviceda | Aviceda Therapeutics
Among several recognitions, he has received the Creativity in Carbohydrate Science Award by the European Carbohydrate Association (2003), the Horace Isbell Award by the Division of …See details»
Aviceda Therapeutics Management Team | Org Chart
Avicedarx.com; 1 601434XXXX; View Similar People. Related Companies Converge Consulting, LLC. 38 $769k Amylyx Pharmaceuticals. 237 $4m Eutropics. 6 $1m Vizgen. 158 Likarda. 14 …See details»
Aviceda Therapeutics Company Profile | Management and
Smith@avicedarx.com: Aviceda Therapeutics Top Competitors. Company Employees Revenue Top technologies; Bluesphere Bio Inc. 12: $2.7 M: AsclepiX Therapeutics Inc. 12: $5.7 M: …See details»
Aviceda Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Www.avicedarx.com. Last update 15 Feb 2025. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & Funding(NIH) Investment. Financing. Overview. ... The statistics for drugs in the …See details»
Aviceda Therapeutics - VentureRadar
"Aviceda Therapeutics is an innovative biotech company focused on harnessing the promise of immune cells’ natural checkpoints, which modulate innate immune activity that is dysregulated …See details»
Aviceda Therapeutics - Overview, News & Similar companies
Oct 11, 2023 www.avicedarx.com. Revenue <$5 Million. Industry Medical Testing & Clinical Laboratories Healthcare . Most Recent Scoops. Jan 9 2024. Project. Oct 11 2023. Event. …See details»
Aviceda Therapeutics (USA) Funding: $276.8M
Jan 14, 2025 Aviceda Therapeutics is a late-stage, pre-clinical biotech company developing drugs for treating glyco-immune...See details»
avicedarx.com Reviews | check if site is scam or legit| Scamadviser
Check avicedarx.com with our free review tool and find out if avicedarx.com is legit and reliable. Need advice? Report scams Check Scamadviser!See details»
Aviceda Therapeutics Appoints Biopharma and …
May 16, 2023 “It is a privilege to join Aviceda’s board as the organization advances towards delivering new treatment options for people living with retinal diseases, many of whom have been significantly ...See details»
Aviceda Therapeutics Appoints Patrick Johnson to its Board of …
May 16, 2023 “It is a privilege to join Aviceda’s board as the organization advances towards delivering new treatment options for people living with retinal diseases, many of whom have …See details»
Pipeline and Programs | Aviceda Therapeutics
Multiple targets under investigation across broad therapeutic areas. Active preclinical, IND, and clinical programs, with 1 recruiting clinical trial in Geographic Atrophy already underway.See details»
Aviceda Therapeutics Completes Enrollment of Phase 2b SIGLEC …
Sep 24, 2024 Organization: Aviceda Therapeutics Inc. avicedapr@avicedarx.com. Twitter; LinkedIn; Facebook; Email Print Massachusetts Phase II. LATEST. Cardiovascular disease. …See details»
Aviceda Therapeutics
Developing Next Generation Immunomodulators That Harness the Power of Glyco-immunology. Avicida's mission is to develop breakthrough glyco-therapeutics that modulate inflammation …See details»
Aviceda Therapeutics Announces Addition of Erin Lavelle to Board …
Sep 10, 2024 “We are excited to welcome Ms. Lavelle to the Board,” said Mohamed Genead, MD, Co-founder and CEO of Aviceda.“Ms. Lavelle’s record of building innovative …See details»
Aviceda Careers | Aviceda Therapeutics
Aviceda Therapeutics is a private clinical-stage biotech company focused on the next generation of glyco-immune therapeutics that leverage the Glyco-Code® technology platform to address …See details»
Aviceda Therapeutics Announces Topline Data from Part 1 of
Jan 16, 2024 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Aviceda Therapeutics, a clinical-stage biotech company focused on developing novel glyco-immune therapeutics by harnessing the …See details»
Garantex Cryptocurrency Exchange Disrupted in International …
Mar 7, 2025 Garantex Splash Page. In conjunction with the operation targeting Garantex, the Department also announced the unsealing of an indictment in the Eastern District of Virginia …See details»
Our Approach | Aviceda Therapeutics
Our body’s immune cells detect damaged and non-self cells through complex interactions, scanning their milieu for glycosylation patterns presented on the surface of all cells.See details»
Comprehensive Ocular and Systemic Safety Evaluation of Polysialic …
* Correspondence: vsendra@avicedarx.com (V.G.S.); mtolentino@avicedarx.com (M.J.T.) Abstract: An inflammation-resolving polysialic acid-decorated PLGA nanoparticle (PolySia …See details»